dc.date.accessioned | 2020-04-01T20:33:46Z | |
dc.date.available | 2020-04-01T20:33:46Z | |
dc.date.issued | 2020-03-17 | |
dc.identifier.uri | https://clinicaltrials.gov/ct2/show/NCT04292964 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/897 | |
dc.description.abstract | The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than SARS and MERS and the number keeps growing. Epidemic studies have been well described clinical features of patients with COVID-19, with the disease severity being an independent predictor of poor outcome. However, there is still no research investigating the prognostic factors of patients with COVID-19. | en_US |
dc.language | English | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | SARS Virus | en_US |
dc.subject | Severe Acute Respiratory Syndrome | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Clinical Trial | en_US |
dc.title | Prognostic Factors of Patients With COVID-19 | en_US |
eihealth.country | Others | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.type | Research protocol information | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.relation.ispartofjournal | ClinicalTrials.gov | en_US |
dc.contributor.corporatename | Chongqing Medical University | |